ccwilloe

[TimAlerts] log 'em into a watch list - long term - any good news can gyrate em up again. watch premarket activity - AQXP a great example.

ccwilloe

[TimAlerts] Its (ATNM) Iomab-B is in preparation for a Phase III multicenter clinical trial for bone marrow conditioning for HSCT in relapsed and refractory AML patients.

Page
of 16